US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Klotho Neurosciences, Inc.

0.9418

-0.0092-0.97%

Pre-market: 0.94180.00000.00%06:08 EDT

Volume:1.13M

Turnover:1.07M

Market Cap:49.64M

PE:-2.73

High:0.9821

Open:0.9800

Low:0.9300

Close:0.9510

52wk High:3.91

52wk Low:0.1135

Shares:52.70M

Float Shares:40.08M

Volume Ratio:1.10

T/O Rate:2.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3455

EPS(LYR):-0.3195

ROE:-1544.44%

ROA:-151.41%

PB:77.71

PE(LYR):-2.95

Loading ...

Overview Company News Filings

Klotho Neurosciences Inc. Expands Beyond Neurology to Enhance Longevity and Health

Klotho Neurosciences seeking to expand into adjacent technologies

Klotho Neuroscience Inc. Expands Focus Beyond Neurology to Enhance Muscle Strength, Bone Health, and Longevity

Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology

THOMSON REUTERS

Klotho Neurosciences Collaborating With AAVnerGene on Gene Therapy Manfuacturing

MT Newswires Live

Klotho Neurosciences partners with AAVnerGene to make gene therapy assets

Klotho Neurosciences Inc. Enters Strategic Partnership with AAVnerGene Inc. to Advance Gene Therapy Innovations

Klotho Neurosciences Granted FDA Orphan Drug Designation for KLTO-202 in ALS Treatment Development

BRIEF-Klotho Neurosciences Inc Files For Mixed Shelf Of Up To $100 Million

Top Midday Gainers

MT Newswires Live

Klotho Neurosciences moves forward with KLTO-202 manufacturing and development

BRIEF-Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for Treatment of ALS

Klotho Neuroscience Inc. Announces New Clinical Study on Klotho Protein's Role in Longevity and Neurodegenerative Disease Prevention in Partnership with Okinawa Research Center

Klotho Neurosciences Inc. Terminates Share Exchange Agreement with Skybell Technologies, Completes $500,000 Series B Preferred Stock Purchase

Klotho Neuroscience Inc. Amends Warrant Pricing and Corrects Stock Purchase to 6.25 Million Shares for $500,000

Why Is Klotho Neurosciences Stock (KLTO) Up 175% Today?

Klotho Neurosciences Shares Soar on Positive Anti-Aging Research

MT Newswires Live

US Stocks Mixed; Motorcar Parts of America Posts Upbeat Earnings

Klotho Neuroscience Inc. Conducted Special Stockholder Meeting

Klotho Neurosciences Q1 EPS $(0.08)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KLTO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KLTO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLTO\",,,,,undefined,":{"symbol":"KLTO","market":"US","secType":"STK","nameCN":"Klotho Neurosciences, Inc.","latestPrice":0.9418,"timestamp":1754596800000,"preClose":0.951,"halted":0,"volume":1126125,"hourTrading":{"tag":"盘前","latestPrice":0.9418,"preClose":0.9418,"latestTime":"06:08 EDT","volume":788,"amount":742.1383999999999,"timestamp":1754647711936},"delay":0,"floatShares":40075700,"shares":52703070,"eps":-0.345529,"marketStatus":"Pre-Mkt","change":-0.0092,"latestTime":"08-08 07:46:29 EDT","open":0.98,"high":0.9821,"low":0.93,"amount":1068225.1705125,"amplitude":0.054784,"askPrice":1.01,"askSize":400,"bidPrice":0.9418,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-0.345529,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1754659800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9418,"preHourTrading":{"tag":"盘前","latestPrice":0.9418,"preClose":0.9418,"latestTime":"06:08 EDT","volume":788,"amount":742.1383999999999,"timestamp":1754647711936},"postHourTrading":{"tag":"盘后","latestPrice":0.947,"preClose":0.9418,"latestTime":"19:57 EDT","volume":9186,"amount":8700.6189,"timestamp":1754611042312},"volumeRatio":1.0986060179551167},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLTO\",,,,,undefined,":{"symbol":"KLTO","floatShares":40075700,"roa":"-151.41%","roe":"-1544.44%","lyrEps":-0.319544,"volumeRatio":1.0986060179551167,"shares":52703070,"dividePrice":0,"high":0.9821,"amplitude":0.054784,"preClose":0.951,"low":0.93,"week52Low":0.1135,"pbRate":"77.71","week52High":3.9099,"institutionHeld":0,"latestPrice":0.9418,"committee":-0.895735,"eps":-0.345529,"divideRate":0,"volume":1126125,"delay":0,"ttmEps":-0.345529,"open":0.98,"prevYearClose":0.485,"prevWeekClose":0.9199,"prevMonthClose":0.9638,"prevQuarterClose":1.13,"fiveDayClose":0.9638,"twentyDayClose":1.46,"sixtyDayClose":0.1744},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLTO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLTO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLTO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLTO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLTO","date":"2025-08-07","current":-6.498782,"percent":0.237443,"low":-11.550846,"twenty":-6.747604,"median":-2.228091,"eighty":-0.888858,"high":-0.602627,"avg":-3.829062,"sd":3.082471,"marketCap":50120619},"quantilePoints":[{"date":"2024-09-20","current":-10.133053,"twenty":-10.825067,"median":-10.565562,"eighty":-10.306056,"marketCap":14128202},{"date":"2024-09-27","current":-8.904729,"twenty":-10.543071,"median":-10.243033,"eighty":-9.44104,"marketCap":12415588},{"date":"2024-10-04","current":-6.660629,"twenty":-10.252919,"median":-9.175356,"eighty":-7.866462,"marketCap":9286708},{"date":"2024-10-11","current":-6.081068,"twenty":-10.221037,"median":-8.087906,"eighty":-6.387036,"marketCap":8478644},{"date":"2024-10-18","current":-8.997886,"twenty":-9.96005,"median":-7.949504,"eighty":-6.316342,"marketCap":12545473},{"date":"2024-10-25","current":-8.326857,"twenty":-10.252919,"median":-8.564768,"eighty":-6.384811,"marketCap":11609879},{"date":"2024-10-31","current":-7.776309,"twenty":-10.243033,"median":-8.326857,"eighty":-6.413481,"marketCap":10842266},{"date":"2024-11-08","current":-5.947755,"twenty":-10.133053,"median":-7.79828,"eighty":-6.377644,"marketCap":8292770},{"date":"2024-11-15","current":-4.19393,"twenty":-9.268037,"median":-7.320314,"eighty":-6.176219,"marketCap":5847466},{"date":"2024-11-22","current":-1.860362,"twenty":-9.082676,"median":-6.590141,"eighty":-5.474984,"marketCap":7831352},{"date":"2024-11-29","current":-1.959871,"twenty":-9.014844,"median":-6.452407,"eighty":-5.301128,"marketCap":8250243},{"date":"2024-12-06","current":-2.288705,"twenty":-8.92336,"median":-6.390024,"eighty":-3.849153,"marketCap":9634498},{"date":"2024-12-13","current":-2.228596,"twenty":-8.735244,"median":-6.278779,"eighty":-2.377203,"marketCap":9381462},{"date":"2024-12-20","current":-2.318508,"twenty":-8.590389,"median":-6.176219,"eighty":-2.282139,"marketCap":9759953},{"date":"2024-12-27","current":-2.32861,"twenty":-8.449473,"median":-6.081068,"eighty":-2.281129,"marketCap":9802480},{"date":"2025-01-03","current":-3.533325,"twenty":-8.354308,"median":-5.474984,"eighty":-2.285371,"marketCap":14873828},{"date":"2025-01-10","current":-2.26354,"twenty":-8.279067,"median":-5.322478,"eighty":-2.28426,"marketCap":9528563},{"date":"2025-01-17","current":-2.131613,"twenty":-8.032545,"median":-5.162346,"eighty":-2.266452,"marketCap":8973203},{"date":"2025-01-24","current":-2.220514,"twenty":-7.811101,"median":-4.595785,"eighty":-2.228596,"marketCap":9347441},{"date":"2025-01-31","current":-1.998261,"twenty":-7.785459,"median":-3.030729,"eighty":-2.172022,"marketCap":8411846},{"date":"2025-02-07","current":-1.82854,"twenty":-7.776309,"median":-2.505655,"eighty":-2.131613,"marketCap":7697392},{"date":"2025-02-14","current":-1.863898,"twenty":-7.320314,"median":-2.470044,"eighty":-2.105347,"marketCap":7846237},{"date":"2025-02-21","current":-1.889659,"twenty":-6.795692,"median":-2.449839,"eighty":-2.026649,"marketCap":7954680},{"date":"2025-02-28","current":-1.752772,"twenty":-6.66141,"median":-2.406147,"eighty":-1.959871,"marketCap":7378439},{"date":"2025-03-07","current":-1.471419,"twenty":-6.547849,"median":-2.374071,"eighty":-1.923503,"marketCap":6194061},{"date":"2025-03-14","current":-1.41434,"twenty":-6.4881,"median":-2.341238,"eighty":-1.854604,"marketCap":5953784},{"date":"2025-03-21","current":-1.769118,"twenty":-6.435724,"median":-2.288705,"eighty":-1.827463,"marketCap":7447251},{"date":"2025-03-28","current":-1.685487,"twenty":-6.415705,"median":-2.270819,"eighty":-1.814878,"marketCap":7095199},{"date":"2025-04-04","current":-0.779795,"twenty":-6.394715,"median":-2.239461,"eighty":-1.78533,"marketCap":4796030},{"date":"2025-04-11","current":-0.767654,"twenty":-6.38012,"median":-2.22405,"eighty":-1.747014,"marketCap":4721360},{"date":"2025-04-17","current":-0.775071,"twenty":-6.331668,"median":-2.184145,"eighty":-1.702218,"marketCap":4766977},{"date":"2025-04-25","current":-0.737059,"twenty":-6.274332,"median":-2.166971,"eighty":-1.642089,"marketCap":4533190},{"date":"2025-05-02","current":-0.842287,"twenty":-6.20909,"median":-2.126814,"eighty":-1.497887,"marketCap":5180381},{"date":"2025-05-09","current":-0.741695,"twenty":-6.176713,"median":-2.114439,"eighty":-1.462652,"marketCap":4561701},{"date":"2025-05-16","current":-0.728264,"twenty":-6.13156,"median":-2.078575,"eighty":-1.411714,"marketCap":5616594},{"date":"2025-05-23","current":-0.698689,"twenty":-6.089356,"median":-2.020991,"eighty":-0.875505,"marketCap":5388509},{"date":"2025-05-30","current":-0.80685,"twenty":-6.027743,"median":-1.998261,"eighty":-0.846954,"marketCap":6222675},{"date":"2025-06-06","current":-0.822018,"twenty":-5.758647,"median":-1.948506,"eighty":-0.831568,"marketCap":6339655},{"date":"2025-06-13","current":-8.426629,"twenty":-6.106298,"median":-1.959871,"eighty":-0.833851,"marketCap":64988778},{"date":"2025-06-20","current":-6.319972,"twenty":-6.240725,"median":-2.020486,"eighty":-0.835056,"marketCap":48741583},{"date":"2025-06-27","current":-4.761046,"twenty":-6.240725,"median":-2.04448,"eighty":-0.838579,"marketCap":36718659},{"date":"2025-07-03","current":-4.803179,"twenty":-6.177455,"median":-2.100801,"eighty":-0.842287,"marketCap":37043603},{"date":"2025-07-11","current":-9.977099,"twenty":-6.377644,"median":-2.12151,"eighty":-0.853954,"marketCap":76946482},{"date":"2025-07-18","current":-9.293736,"twenty":-6.480211,"median":-2.144241,"eighty":-0.863729,"marketCap":71676175},{"date":"2025-07-25","current":-8.678709,"twenty":-6.660629,"median":-2.171517,"eighty":-0.867943,"marketCap":66932898},{"date":"2025-08-01","current":-6.586252,"twenty":-6.741303,"median":-2.208391,"eighty":-0.884796,"marketCap":50795218},{"date":"2025-08-07","current":-6.498782,"twenty":-6.747604,"median":-2.228091,"eighty":-0.888858,"marketCap":50120619}],"updateTime":1754642143622},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KLTO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554901537","title":"Klotho Neurosciences Inc. Expands Beyond Neurology to Enhance Longevity and Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2554901537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554901537?lang=en_us&edition=fundamental","pubTime":"2025-07-26 09:06","pubTimestamp":1753491966,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc.  has announced plans to expand its development programs beyond neurology, with a focus on technologies that enhance brain function, muscle strength, bone health, and other indicators of longevity. The company is evaluating the acquisition of complementary technologies to support healthy brain function, organ health, and longevity, in addition to its core programs targeting neurodegenerative diseases like ALS, Alzheimer's, and Parkinson's. This expansion aims to slow biological aging and reduce age-related diseases by exploring genes and proteins such as alpha-Klotho, beta-Klotho, and FOXO3. CEO Dr. Joseph Sinkule emphasized the company's mission to identify and develop assets to delay age-related health outcomes through targeted research and intervention.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inform","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250726:nNDL4kJN4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2554782285","title":"Klotho Neurosciences seeking to expand into adjacent technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782285?lang=en_us&edition=fundamental","pubTime":"2025-07-25 01:35","pubTimestamp":1753378520,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (KLTO)announced that it is evaluating the acquisition of “several complementary technologies” aimed at supporting healthy brai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/klotho-neurosciences-seeking-to-expand-into-adjacent-technologies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/klotho-neurosciences-seeking-to-expand-into-adjacent-technologies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2554782162","title":"Klotho Neuroscience Inc. Expands Focus Beyond Neurology to Enhance Muscle Strength, Bone Health, and Longevity","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782162","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782162?lang=en_us&edition=fundamental","pubTime":"2025-07-25 01:30","pubTimestamp":1753378241,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc.  has announced plans to broaden its development programs beyond neurology to include technologies aimed at enhancing muscle strength, bone health, and other indicators of longevity. The company is exploring the acquisition of complementary technologies to support healthy brain function, organ health, and overall longevity. In addition to its core focus on neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's, Klotho aims to expand its anti-aging platform to slow biological aging and mitigate age-related diseases. The company's efforts will include research into key longevity indicators like alpha-Klotho, beta-Klotho, and FOXO3, with the intention of promoting healthier, longer lives.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nNDL1rD8QW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2554782154","title":"Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology","url":"https://stock-news.laohu8.com/highlight/detail?id=2554782154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554782154?lang=en_us&edition=fundamental","pubTime":"2025-07-25 01:30","pubTimestamp":1753378228,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL1DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2553252211","title":"Klotho Neurosciences Collaborating With AAVnerGene on Gene Therapy Manfuacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2553252211","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553252211?lang=en_us&edition=fundamental","pubTime":"2025-07-22 23:45","pubTimestamp":1753199156,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences  said Tuesday it is collaborating with AAVnerGene on adeno-associated virus manufacturing and targeted tissue delivery for its therapies to treat Alzheimer's, Parkinson's, ALS, and other conditions.The collaboration will concentrate on producing KLTO-101 for Alzheimer's and Parkinson's diseases, KLTO-202 for ALS and other motor neuron disorders, and KLTO-303 for aging-related conditions, the company said.\"The two platform technologies offered by AAVnerGene will catapult our product candidates into the clinic at a faster pace, at a lower cost, a higher efficacy and purity compared to the current state-of-the-art AAV manufacturing processes,\" said Klotho CEO Joseph Sinkule.Financial terms of the collaboration were not disclosed.Price: 1.19, Change: -0.01, Percent Change: -0.83","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KLTO"],"gpt_icon":0},{"id":"2553615254","title":"Klotho Neurosciences partners with AAVnerGene to make gene therapy assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2553615254","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553615254?lang=en_us&edition=fundamental","pubTime":"2025-07-22 22:30","pubTimestamp":1753194620,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (KLTO)is partnering with AAVnerGene. Joseph Sinkule, CEO of KLTO stated “we announced previously that we have been looking for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/klotho-neurosciences-partners-with-aavnergene-to-make-gene-therapy-assets-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/klotho-neurosciences-partners-with-aavnergene-to-make-gene-therapy-assets-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2553251701","title":"Klotho Neurosciences Inc. Enters Strategic Partnership with AAVnerGene Inc. to Advance Gene Therapy Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2553251701","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553251701?lang=en_us&edition=fundamental","pubTime":"2025-07-22 22:21","pubTimestamp":1753194104,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc.  has announced a strategic partnership with AAVnerGene Inc., a biotech company based in Rockville, MD, known for its advanced AAV manufacturing and tissue-targeted delivery technologies. This collaboration aims to address challenges in AAV gene therapy, including high drug costs and dose-related toxicity, by leveraging AAVnerGene's proprietary platforms. The partnership will utilize the AAVone system to reduce manufacturing costs and the ATHENA platform for efficient tissue-targeted delivery. Klotho Neurosciences plans to apply these technologies to accelerate the development of its gene therapy candidates, such as KLTO-101 for Alzheimer's and Parkinson's diseases, KLTO-202 for ALS, and KLTO-303 for aging-related conditions. The collaboration is expected to result in more affordable and innovative treatments for both rare and common neurological diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDL1BwLvn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2550051612","title":"Klotho Neurosciences Granted FDA Orphan Drug Designation for KLTO-202 in ALS Treatment Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2550051612","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550051612?lang=en_us&edition=fundamental","pubTime":"2025-07-10 17:00","pubTimestamp":1752138025,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences, Inc., a gene and cell therapy company, has announced that the U.S. Food and Drug Administration  has granted Orphan Drug Designation for their novel gene therapy, KLTO-202, aimed at treating Amyotrophic Lateral Sclerosis . The designation is a significant milestone for the company, as it provides incentives like tax credits for clinical trials and market exclusivity for seven years upon approval. KLTO-202 targets motor neuron diseases by delivering therapeutic concentrations of the s-KL protein to neuromuscular junctions, potentially offering a new treatment option for this rare and fatal condition. Currently, the product is not approved for human use, and Klotho Neurosciences is preparing for meetings with the FDA and EMA to discuss the development path forward.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL8nBTz0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2549533721","title":"BRIEF-Klotho Neurosciences Inc Files For Mixed Shelf Of Up To $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2549533721","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549533721?lang=en_us&edition=fundamental","pubTime":"2025-07-07 18:18","pubTimestamp":1751883527,"startTime":"0","endTime":"0","summary":"BRIEF-Klotho Neurosciences Inc Files For Mixed Shelf Of Up To $100 MillionJuly 7  - Klotho Neurosciences Inc KLTO.O:KLOTHO NEUROSCIENCES INC FILES FOR MIXED SHELF OF UP TO $100 MILLION – SEC FILINGKLOTHO NEUROSCIENCES : SALES AGREEMENT PROSPECTUS FOR OFFER OF UP TO $50 MILLION COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIMEFurther company coverage: KLTO.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nFWN3T301M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2548686011","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2548686011","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548686011?lang=en_us&edition=fundamental","pubTime":"2025-07-01 01:12","pubTimestamp":1751303543,"startTime":"0","endTime":"0","summary":"Artelo Biosciences  said Monday its first-in-human study of its non-opioid analgesic ART26.12 affirmed the \"promising\" safety and pharmacokinetic profile observed in preclinical trials.Shares more than doubled as intraday trading volume catapulted to over 24.5 million from a daily average of about 73,000.HC Wainwright upgraded Vor Biopharma  to a buy rating from neutral, with a price target of $3.Shares surged 52%, with trading volume of over 52.9 million against a daily average of about 12.6 million.Klotho Neurosciences  said it is progressing with manufacturing and process development work for trials of KLTO-202, its gene therapy candidate for amyotrophic lateral sclerosis.Shares advanced 61% as intraday trading volume soared to over 124.1 million from a daily average of about 39.2 million.Price: 14.08, Change: +7.30, Percent Change: +107.67","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VOR","ARTL","BK4007","BK4139","KLTO"],"gpt_icon":1},{"id":"2547064459","title":"Klotho Neurosciences moves forward with KLTO-202 manufacturing and development","url":"https://stock-news.laohu8.com/highlight/detail?id=2547064459","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547064459?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:20","pubTimestamp":1751275223,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (KLTO)announced that it is moving forward with manufacturing and process development work in preparation for clinical trials o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/klotho-neurosciences-moves-forward-with-klto-202-manufacturing-and-development-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/klotho-neurosciences-moves-forward-with-klto-202-manufacturing-and-development-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2547549320","title":"BRIEF-Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for Treatment of ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2547549320","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547549320?lang=en_us&edition=fundamental","pubTime":"2025-06-30 14:57","pubTimestamp":1751266624,"startTime":"0","endTime":"0","summary":"BRIEF-Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for Treatment of ALSJune 30 (Reuters) - Klotho Neurosciences Inc KLTO.O:KLOTHO NEUROSCIENCES: MOVES FORWARD WITH MANUFACTURING ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX03F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2545404918","title":"Klotho Neuroscience Inc. Announces New Clinical Study on Klotho Protein's Role in Longevity and Neurodegenerative Disease Prevention in Partnership with Okinawa Research Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2545404918","media":"Reuters","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545404918?lang=en_us&edition=fundamental","pubTime":"2025-06-24 17:00","pubTimestamp":1750755619,"startTime":"0","endTime":"0","summary":"Klotho Neuroscience Inc. Announces New Clinical Study on Klotho Protein's Role in Longevity and Neurodegenerative Disease Prevention in Partnership with Okinawa Research Center. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via CNW  on June 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nNDL9fN77M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2543658184","title":"Klotho Neurosciences Inc. Terminates Share Exchange Agreement with Skybell Technologies, Completes $500,000 Series B Preferred Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2543658184","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543658184?lang=en_us&edition=fundamental","pubTime":"2025-06-14 05:15","pubTimestamp":1749849337,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences Inc. Terminates Share Exchange Agreement with Skybell Technologies, Completes $500,000 Series B Preferred Stock Purchase. On June 9, 2025, Klotho Neurosciences, Inc. entered into a Stock Purchase Agreement for the sale of Series B Preferred stock totaling $500,000. Although the specific number of shares was not disclosed, these shares are convertible into the Company's Common Stock following SEC approval. The transaction was conducted without underwriters and no sales commissions were paid. The agreement was part of a private placement relying on an exemption from registration under the Securities Act of 1933.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content use","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL98X4Cs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KLTO"],"gpt_icon":1},{"id":"2542889565","title":"Klotho Neuroscience Inc. Amends Warrant Pricing and Corrects Stock Purchase to 6.25 Million Shares for $500,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2542889565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542889565?lang=en_us&edition=fundamental","pubTime":"2025-06-11 18:04","pubTimestamp":1749636255,"startTime":"0","endTime":"0","summary":"Klotho Neuroscience Inc. recently amended its April 2022 Public Warrant to allow a temporary repricing of the exercise price to $1.35 from June 10 to June 20, 2025. Additionally, the company entered into a Stock Purchase Agreement on June 5, 2025, for the sale of 6,250,000 shares of its common stock for a total purchase price of $500,000. The transactions were conducted without underwriters or sales commissions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the informatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL4cFg63:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":1},{"id":"2542332212","title":"Why Is Klotho Neurosciences Stock (KLTO) Up 175% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2542332212","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542332212?lang=en_us&edition=fundamental","pubTime":"2025-06-10 03:24","pubTimestamp":1749497040,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences stock rocketed on Monday after it announced a new approach to treating age-related issues.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-klotho-neurosciences-stock-klto-up-175-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-klotho-neurosciences-stock-klto-up-175-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KLTO"],"gpt_icon":0},{"id":"2542516333","title":"Klotho Neurosciences Shares Soar on Positive Anti-Aging Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2542516333","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542516333?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:32","pubTimestamp":1749479522,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (KLTO) shares surged by more than 400% in recent trading on Monday after the company said that initial findings in preclinical studies showed the potential of elevating Klotho gen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","KLTO"],"gpt_icon":1},{"id":"2542233893","title":"US Stocks Mixed; Motorcar Parts of America Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2542233893","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542233893?lang=en_us&edition=fundamental","pubTime":"2025-06-09 22:04","pubTimestamp":1749477899,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/06/45837586/us-stocks-mixed-motorcar-parts-of-america-posts-upbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWNP","RSLS","MPAA","PLCE","KNW","NUWE","KLTO"],"gpt_icon":0},{"id":"2540715852","title":"Klotho Neuroscience Inc. Conducted Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540715852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540715852?lang=en_us&edition=fundamental","pubTime":"2025-06-03 04:47","pubTimestamp":1748897269,"startTime":"0","endTime":"0","summary":"Klotho Neuroscience Inc. held a special meeting of stockholders on May 28, 2025. Stockholders approved the proposal to amend the Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's outstanding common stock at an exchange ratio between one-for-2 to one-for-50, as determined by the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klotho Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL1NCSjL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO","BK4139"],"gpt_icon":0},{"id":"2535382365","title":"Klotho Neurosciences Q1 EPS $(0.08)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535382365","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535382365?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:13","pubTimestamp":1747314820,"startTime":"0","endTime":"0","summary":"Klotho Neurosciences (NASDAQ:KLTO) reported quarterly losses of $(0.08) per share.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45436737/klotho-neurosciences-q1-eps-0-08","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLTO"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}